A replay of “Wearables Webinar Series, Part 3: Product Liability and IP Strategies for Wearables” is now available for viewing.
“Confidential” vs. “Trade Secret” – A Non-Binary Dilemma
Virtually all life sciences companies use routine protocols which they believe will protect their intellectual property and other confidential or “trade secret” information. Among these routine proactive protocols are having a standard confidentiality/nondisclosure agreement (sometimes referred to below as “NDA”), limiting access to confidential and trade secret information, periodic internal audits of safeguarding methods, and more. But are “trade secrets” the same as “confidential information?” Continue reading ““Confidential” vs. “Trade Secret” – A Non-Binary Dilemma”